# Project Status

## Current Maturity

This is a mature interview-ready machine learning project. It has a reproducible pipeline, real large-scale biomedical data, documented technical choices, generated visualizations, validation metrics, unit tests, and a clear explanation of limitations.

## What Is Complete

- Tahoe-100M data streaming
- Sparse expression matrix construction
- CPM-style log normalization
- TruncatedSVD dimensionality reduction
- KMeans clustering
- Cluster visualization
- Drug-by-cluster heatmap
- Cluster quality metrics
- Structured output tables
- Supervised mechanism-of-action benchmark
- README, interview notes, requirements, and tests

## Main Technical Strength

The strongest part of the project is that it handles high-dimensional biological data using memory-aware methods. The pipeline streams the dataset, uses sparse matrices, and applies ML methods that are appropriate for sparse transcriptomic data.

## Honest Limitations

- Clusters are unsupervised and need biological validation.
- The demo uses a 20,000-cell sample rather than the full Tahoe-100M dataset.
- The current workflow does not apply batch-effect correction.
- It does not yet train a supervised predictor for mechanism of action or drug response.

## Best Next Step

The best next improvement would be deeper biological validation: compare clusters against known pathway annotations, add batch-effect correction, and evaluate on a larger sample across more plates.
